I just posted the second part of my interview with Jan Geissler and Giora Sharf on adherence in CML. See: bkoffman.blogspot.com This is going to a critical issue in the CLL world going forward with the approval (USA only so far) of oral meds such as ibrutinib and with more to come
We have much we can learn from our CML friends and much work we can do together to make things better for all of us with CLL. I have some ideas that I will be sharing here and on my blog soon.
Stay strong. We are all in this together.